Geranylgeranyl pyrophosphate (triammonium)

Geranylgeranyl pyrophosphate triammonium is a metabolite involved in protein geranylgeranylation. Geranylgeranyl pyrophosphate triammonium is the common precursor of diterpenoids, for example, Paclitaxel. Geranylgeranyl pyrophosphate triammonium can be used for cancer research[1].

Product Specifications

CAS Number

[313263-08-0]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/geranylgeranyl-pyrophosphate-triammonium.html

Purity

95.0

Solubility

DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : ≥ 25 mg/mL

Smiles

O=P(O)(OP(O)(O)=O)OC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C.N.N.N

Molecular Formula

C20H45N3O7P2

Molecular Weight

501.53

Precautions

H302, H315, H319, H335

References & Citations

[1]Joseph C Utomo, et al. Developing a Yeast Platform Strain for an Enhanced Taxadiene Biosynthesis by CRISPR/Cas9. Metabolites. 2021 Mar 3;11 (3) :147.